Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Humira Biosimilars Not Gaining Traction Epitomizes Dysfunctional U.S. System
Humira Biosimilars Not Gaining Traction Epitomizes Dysfunctional U.S. System
Forbes
Humira
AbbVie
biosimilars
FDA
Flag link:
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
BioSpace
Samsung Bioepsis
JNJ
patents
Stelara
biosimilars
SB17
Flag link:
FDA Accepts sBLA for Interchangeability Designation for Humira biosimilars
FDA Accepts sBLA for Interchangeability Designation for Humira biosimilars
Dermatology Times
Samsung Bioepis
Organon
FDA
AbbVie
Humira
biosimilars
Flag link:
Amgen scores FDA approval for Stelara biosimilar
Amgen scores FDA approval for Stelara biosimilar
Pharmaceutical Technology
Amgen
Stelara
biosimilars
JNJ
FDA
Wezlana
Flag link:
AbbVie Stock Dives As Aesthetics Sales Mar Its Third-Quarter Beat And Guidance Boost
AbbVie Stock Dives As Aesthetics Sales Mar Its Third-Quarter Beat And Guidance Boost
Investors Business Daily
AbbVie
earnings
aesthetics
Humira
biosimilars
Flag link:
FDA approves Celltrion’s subcutaneous Remicade biosimilar for IBD
FDA approves Celltrion’s subcutaneous Remicade biosimilar for IBD
Pharm
Celltrio
Zymfentra
ulcerative colitis
Crohn's Disease
biosimilars
Remicade
Flag link:
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug
Reuters
Roche
legal
Biogen
biosimilars
Actemra
Flag link:
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
BioSpace
Alvotech
AVT04
JNJ
Stelara
biosimilars
FDA
Flag link:
FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
Generics Bulletin
Pfizer
Humira
biosimilars
adalimumab
AbbVie
interchangeability
FDA
Flag link:
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Boehringer Ingelheim
Cyltezo
biosimilars
Humira
drug pricing
Flag link:
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Reuters
Boehringer Ingelheim
biosimilars
AbbVie
Humira
unbranded biosimilars
Flag link:
Biogen nabs FDA nod for biosimilar version of Roche's blockbuster Actemra
Biogen nabs FDA nod for biosimilar version of Roche's blockbuster Actemra
Fierce Pharma
Biogen
Roche
Actemra
autoimmune disease
biosimilars
Flag link:
Coherus hits FDA hurdles for PD-1 drug, Neulasta biosimilar on-body injector
Coherus hits FDA hurdles for PD-1 drug, Neulasta biosimilar on-body injector
Fierce Pharma
Coherus Biosciences
Neulasta
biosimilars
FDA
Junshi Biosciences
Flag link:
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
BioSpace
Alvotech
FDA
biosimilars
AVT02
AbbVie
Humira
Flag link:
Alvotech gets new FDA review for Humira biosimilar
Alvotech gets new FDA review for Humira biosimilar
BioPharma Dive
Alvotech
FDA
Humira
biosimilars
Flag link:
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Medical Marketing and Media
PBMs
biosimilars
Humira
Flag link:
FDA revises biosimilar guidelines for clearer drug labelling
FDA revises biosimilar guidelines for clearer drug labelling
Pharmaceutical Technology
FDA
biosimilars
labeling
Flag link:
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Sandoz
Samsung Bioepis
biosimilars
JNJ
Stelara
Flag link:
AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report
AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report
BioSpace
AbbVie
Humira
biosimilars
Crohn's Disease
Flag link:
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
Motley Fool
Novartis
biosimilars
Eylea
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »